A recent study has found that metformin can significantly inhibit the proliferation of HCC cells and effectively reduce the expression of CDK1.[62] In the present study, the high expression of CDK1 is associated with unfavorable OS and DFS in HCC patients. This evidence concerns the gene CDK1 and hepatocellular carcinoma.